Skip to content
10-Q

Quarterly Report

VERVE THERAPEUTICS, INC.

0000950170-24-121075

← back to feed
Filed
Nov 5, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Oct 29, 2024 84.66M sh
Shares Diluted Q3 2024 · Sep 30, 2024 84.63M sh
Shares Diluted Q3 2024 · Sep 30, 2024 84M sh
Shares Diluted Q3 2024 · Sep 30, 2023 63.21M sh
Shares Diluted Q3 2024 · Sep 30, 2023 62.32M sh
Capex Q3 2024 · Sep 30, 2024 $2.35M
Capex Q3 2024 · Sep 30, 2023 $7.1M
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$116.85M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$108.87M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $158.71M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $206.18M
Cash And Equivalents Q3 2024 · Sep 30, 2023 $78.37M
Stockholders Equity Q3 2024 · Sep 30, 2024 $508.55M
Stockholders Equity Q3 2024 · Jun 30, 2024 $546.09M
Stockholders Equity Q3 2024 · Mar 31, 2024 $583.07M
Stockholders Equity Q3 2024 · Dec 31, 2023 $599.5M
Stockholders Equity Q3 2024 · Sep 30, 2023 $460.37M
Stockholders Equity Q3 2024 · Jun 30, 2023 $465.22M
Stockholders Equity Q3 2024 · Mar 31, 2023 $509.48M
Stockholders Equity Q3 2024 · Dec 31, 2022 $550.93M
Current Liabilities Q3 2024 · Sep 30, 2024 $42.64M
Current Liabilities Q3 2024 · Dec 31, 2023 $37.01M
Total Liabilities Q3 2024 · Sep 30, 2024 $155.36M
Total Liabilities Q3 2024 · Dec 31, 2023 $153.19M
Current Assets Q3 2024 · Sep 30, 2024 $556.46M
Current Assets Q3 2024 · Dec 31, 2023 $637.95M
Total Assets Q3 2024 · Sep 30, 2024 $663.91M
Total Assets Q3 2024 · Dec 31, 2023 $752.69M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.59
Eps Diluted Q3 2024 · Sep 30, 2024 −$1.77
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.72
Eps Diluted Q3 2024 · Sep 30, 2023 −$2.43
Eps Basic Q3 2024 · Sep 30, 2024 −$0.59
Eps Basic Q3 2024 · Sep 30, 2024 −$1.77
Eps Basic Q3 2024 · Sep 30, 2023 −$0.72
Eps Basic Q3 2024 · Sep 30, 2023 −$2.43
Sga Expense Q3 2024 · Sep 30, 2024 $13.84M
Sga Expense Q3 2024 · Sep 30, 2024 $42.55M
Sga Expense Q3 2024 · Sep 30, 2023 $11.69M
Sga Expense Q3 2024 · Sep 30, 2023 $37.66M
Rd Expense Q3 2024 · Sep 30, 2024 $49.94M
Rd Expense Q3 2024 · Sep 30, 2024 $149.3M
Rd Expense Q3 2024 · Sep 30, 2023 $43.77M
Rd Expense Q3 2024 · Sep 30, 2023 $138.14M
Net Income Q3 2024 · Sep 30, 2024 −$50.13M
Net Income Q3 2024 · Sep 30, 2024 −$148.67M
Net Income Q3 2024 · Jun 30, 2024 −$49.81M
Net Income Q3 2024 · Mar 31, 2024 −$48.74M
Net Income Q3 2024 · Sep 30, 2023 −$45.76M
Net Income Q3 2024 · Sep 30, 2023 −$151.72M
Net Income Q3 2024 · Jun 30, 2023 −$53.98M
Net Income Q3 2024 · Mar 31, 2023 −$51.98M
Operating Income Q3 2024 · Sep 30, 2024 −$56.91M
Operating Income Q3 2024 · Sep 30, 2024 −$172.59M
Operating Income Q3 2024 · Sep 30, 2023 −$52.33M
Operating Income Q3 2024 · Sep 30, 2023 −$169.18M